Prevalence and Predictors of Masked Inefficacy of Treatment of Arterial Hypertension During Use of Various Groups of Antihypertensive Drugs

被引：0
|
作者：
Gorbunov, V. M. [1 ]
Smirnova, M. I. [1 ]
Andreeva, G. F. [1 ]
Deev, A. D. [1 ]
Shalnova, S. A. [1 ]
机构：
[1] Res Ctr Prevent Med, Moscow 101990, Russia
来源：
KARDIOLOGIYA | 2009年 / 49卷 / 02期
关键词：
arterial hypertension; masked hypertension; antihypertensive therapy; 24-hour blood pressure monitoring; psychological status; BLOOD-PRESSURE; WHITE-COAT; QUALITY; LIFE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Prevalence and predictors of masked arterial hypertension (AH) in patients receiving antihypertensive therapy (concealed treatment inefficacy - CTI) was studied on material of data base comprising 219 observations. Drugs from 5 groups were used. Prevalence of CTI AH with the use of various definitions was 8.1-17.4%. With the help of procedure of logistic regression analysis the following predictors of CTI were selected: (1) sociopsychological - high working capacity, high psychological abilities and social self feeling; (2) parameters of 24-hour BP profile - 24-hour variability, variability during working period, minimal daytime BP level, time of maximal BP. According to our data CTI is most probable during treatment with calcium antagonists and beta-adrenoblockers
引用
收藏
页码：32 / 37
页数：6
相关论文
共 39 条
  • [21] DEVELOPMENT OF HYPERTENSION AND LIFE-SPAN IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS DURING ORAL LONG-TERM TREATMENT WITH VARIOUS ANTIHYPERTENSIVE DRUGS
    GRIES, J
    KRETZSCHMAR, R
    NEUMANN, BW
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S79 - S82
  • [22] NEWER DRUGS IN THE TREATMENT OF HYPERTENSION .4. USE OF RESERPINE, HYDRALAZINE, AND PENTOLINIUM IN VARIOUS COMBINATIONS
    ORGAIN, ES
    MUNROE, CA
    DONNELLY, GL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 166 (17): : 2103 - 2107
  • [23] Effect of principal antihypertensive drugs on quality of life and psychologic status of patients with stable arterial hypertension during long-term monotherapy
    Mukhamedzhanova, GF
    Metelitsa, VI
    Duda, SG
    Filatova, NP
    Barsov, DA
    KARDIOLOGIYA, 1996, 36 (09) : 18 - 21
  • [24] COMPARATIVE-STUDY IN THE TREATMENT OF ARTERIAL-HYPERTENSION BY THE USE OF CLONIDINE ALONE OR ASSOCIATED WITH OTHER DRUGS
    POSSE, RA
    FATO, SA
    LOPEZ, M
    LAPUENTE, A
    PRENSA MEDICA ARGENTINA, 1983, 70 (14): : 613 - 619
  • [25] Antihypertensive treatment decreases arterial stiffness at night but not during the day. Results from the Hypertension in the Very Elderly Trial
    Bulpitt, Christopher J.
    Webb, Richard
    Beckett, Nigel
    Peters, Ruth
    Cheek, Elizabeth
    Anderson, Craig
    Antikainen, Riitta
    Staessen, Jan A.
    Rajkumar, Chakravarthi
    BLOOD PRESSURE, 2017, 26 (02) : 109 - 114
  • [26] Effect of antihypertensive drugs of various pharmacological groups on reaction of arterial pressure under conditions of stree testing. Part II. Value of various strategies of potentiation of systemic vasodilatation
    Praskurnitchy, E. A.
    Shevtchenko, O. P.
    Makarova, S. V.
    Zhukova, V. A.
    Savelieva, S. A.
    KARDIOLOGIYA, 2008, 48 (04) : 18 - 24
  • [27] LCZ696 - an innovative antihypertensive drug? The treatment of arterial hypertension remains to be a challenging problem despite a variety of anti-hypertensive drugs
    Primus, C.
    Auer, J.
    JOURNAL FUR HYPERTONIE, 2015, 19 (04): : 114 - 117
  • [28] Pentoxifylline treatment enhances antihypertensive activity of captopril through hemorheological improvement in spontaneously hypertensive rats during development of arterial hypertension
    Plotnikov, Mark B.
    Shamanaev, Alexander Y.
    Aliev, Oleg I.
    Sidekhmenova, Anastasia V.
    Anishchenko, Anna M.
    Arkhipov, Alexander M.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2017, 11 (11) : 769 - 778
  • [29] Risk of Pulmonary Arterial Hypertension During Qing-Dai Use for the Treatment of Ulcerative Colitis
    Adachi, Shiro
    Nakano, Yoshihisa
    Kondo, Takahisa
    CIRCULATION JOURNAL, 2020, 84 (08) : 1235 - 1236
  • [30] Left ventricular hypertrophy in hypertension. Part III. Reversibility of left ventricular hypertrophy during treatment with antihypertensive drugs
    Preobrazhensky, DV
    Sidorenko, BA
    Alekhin, MN
    Batyraliev, TA
    Stetsenko, TM
    KARDIOLOGIYA, 2004, 44 (04) : 89 - 94
1234